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The preceding paper describes purification and prop- 
erties of a 150-kDa polyphosphoinositide-specific 
phospholipase C from a cytosolic fraction of turkey 
erythrocytes (Morris, A. J., Waldo, G. L., Downes, C. 
P., and Harden, T. K. (1990) J. Biol. Chem. 265, 
13501-13507). Turkey erythrocytes express a PZu- 
purinergic receptor that employs an unidentified G- 
protein to activate phospholipase C (Boyer, J. L., 
Downes, C. P., and Harden, T. K. (1989) J. Biol. Chem. 
264, 884-890; Cooper, C. L., Morris, A. J., and 
Harden, T. K. (1989) J. Biol. Chem. 264,6202-6206). 
This paper describes receptor and G-protein regulation 
of the purified turkey erythrocyte phospholipase C 
after reconstution of the enzyme using [‘Hlinositol pre- 
labeled turkey erythrocyte ghosts as acceptor mem- 
branes. These membranes contain polyphosphoinosi- 
tides labeled to high specific radioactivity and display 
reduced responsiveness of their endogenous phospho- 
lipase C to Pzu-purinergic receptor agonists and gua- 
nine nucleotides. Reconstitution of purified enzyme 
had no effect on basal inositol phosphate production, 
but markedly increased Pzy-purinergic receptor ago- 
nist and guanine nucleotide-dependent accumulation 
of inositol phosphates. Reconstitution of 5 ng of puri- 
fied phospholipase C with 10 rg of acceptor membrane 
protein produced half-maximal effects, and maximal 
activity was observed with reconstitution of 100 ng of 
purified enzyme. Agonist and guanine nucleotide-reg- 
ulated phospholipase C activity measured using a re- 
constitution assay co-purified with phospholipase C 
activity detected using exogenously provided phospha- 
tidylinositol 4,5-bisphosphate during purification of 
the 150-kDa protein. Only the maximal rate of inositol 
phosphate formation attained upon activation was in- 
creased in the presence of the purified phospholipase 
C. I&, values for adenosine 5’-0-(2-thiodiphosphate), 
guanosine 5’-3-0-(thio)triphosphate, and AlF,- acti- 
vation of the purified enzyme were the same as for the 
endogenous phospholipase C activity of the acceptor 
membranes. 
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Inositol lipid-specific phospholipase C (PLC)’ plays a cen- 
tral role in the signal transduction mechanism employed by a 
large group of cell surface receptors. There have been recent 
parallel advances in understanding of both the mechanisms 
receptors utilize to regulate PLC activity and of the enzymol- 
ogy of the PLC family (reviewed in Refs. 1 and 2). However, 
none of the identified PLC isoenzymes has been directly 
implicated in receptor-mediated inositol lipid hydrolysis. 
Three distinct lines of experimental evidence support a role 
for a G-protein in receptor-mediated regulation of PLC. Thus, 
agonist binding to PLC-coupled receptors is modulated by 
guanine nucleotides (3, 4), and pertussis toxin, a bacterial 
toxin known to inhibit function of a number of G-proteins, 
has been shown, in certain cases, to inhibit receptor-mediated 
activation of PLC (5,6 but see Refs. 7 and 8). The most direct 
evidence for the involvement of a G-protein in receptor reg- 
ulation of PLC comes from studies using cell-free preparations 
where receptor-mediated activation of PLC has been found 
to be absolutely dependent on the presence of guanine nucle- 
otides (see Ref. 1 for review). 
Exogenously provided phospholipid substrates, often pre- 
sented as components of mixed phospholipid and detergent 
micelles, have been used to follow PLC activity during puri- 
fication (2, 12). Several laboratories have reported receptor- 
mediated, guanine nucleotide-dependent activation of PLC 
when phosphoinositide substrates were presented in this form 
to membrane preparations from several cell types (9-11). 
However, these observations have not been extended to sys- 
tems containing purified proteins. Conversely, the most de- 
tailed examinations of receptor-mediated regulation of PLC 
have used cell-free preparations in which the sources of sub- 
strates were endogenously labeled inositol lipids (see Ref. 1 
for review). While clearly of greater physiological relevance 
than that of assays requiring exogenously provided substrates, 
this approach has several drawbacks. The most prominent of 
these relates to the inherent inability to vary substrate con- 
centration and substrate-specific radioactivity without coin- 
cidently producing a parallel change in the amounts of the 
proteins responsible for receptor-stimulated inositol lipid hy- 
drolysis. 
1 The abbreviations used are: PLC, phospholipase C; G-protein, 
guanine nucleotide-dependent regulatory protein; PtdIns4P, phos- 
phatidylinositol4-phosphate; PtdIns(4,5)Pz, phosphatidylinositol 
4,5-bisphosphate; Ins(l,4)P2, myo-inositol 1,4-bisphosphate; 
Ins(1,4,5)P3, myo-inositol 1,4,5-trisphosphate; SDS-PAGE, sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis; EGTA, [ethylene- 
bis(oxyethylenenitrilo)]tetraacetic acid; HEPES, 4-(2-hydroxyethyl)- 
l-ninerazineethanesulfonic acid: ADPBS, adenosine 5’-0-(2-thiodi- 
phosphate); GTPrS, guanosine. 5’-3-0-(thio)triphosphate; GDPPS, 
guanosine 5’-0-(2-thiodiphosphate). 
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The preceding paper describes the purification and prop- 
erties of a PLC from turkey erythrocytes (12). In this report, 
we describe the regulation of the purified PLC when recon- 
stituted with [3H]inositol-labeled turkey erythrocyte ghosts. 
The results demonstrate that this isoenzyme of PLC can 
function as a catalytic component of the machinery used by 
cell surface receptors and their associated G-proteins to gen- 
erate inositol lipid-derived second messengers. 
EXPERIMENTAL PROCEDURES 
Purification of PLC-PLC was purified from turkey erythrocytes 
exactly as described previously (12). The mass of the purified PLC 
was estimated by sodium dodecyl sulfate-polyacrylamide gel electro- 
phoresis and staining with Coomassie Brilliant Blue. 
PH]Inositol Labeling of Turkey Erythrocytes-Turkey erythrocytes 
were labeled with [3H]inositol using the method described (13) except 
that chicken serum was omitted from the incubations. One ml of 
washed, packed cells was incubated with 2 mCi of [“Hlinositol for 24 
h. Ghosts were prepared from the labeled cells by hypotonic lysis and 
repeated centrifugation as described below (14). 
PLC Assay-PLC activity against ‘H-labeled inositol lipids of 
turkey erythrocyte ghosts was determined as described (13). Briefly, 
the ghosts were prepared by hypotonic lysis of 1 ml of turkey eryth- 
rocytes in 40 ml of buffer containing 5 mM KHgPO,, 5 mM MgC12, 1 
mM EGTA followed by three washes of repeated centrifugation and 
resuspension in this buffer. The ghosts were finally resuspended by 
homogenization in 40 ml of 10 mM HEPES, pH 7.4, sedimented by 
centrifugation, and resuspended in 1 ml of 10 mM HEPES, pH 7.4. 
The assays were started by the addition of prewarmed [3H]inositol- 
labeled turkey erythrocyte ghosts from polyethylene tubes to borosil- 
icate glass tubes containing prewarmed assay buffer plus drugs. In 
some cases, the ghosts were held on ice, and purified turkey erythro- 
cyte PLC was combined with them before dilution with 10 mM 
HEPES, pH 7.4, warming, and addition to the assay medium. The 
assays were performed at 30 “C, and the incubation time was 5 min 
unless otherwise stated. Incubations were terminated with ice cold 
7% perchloric acid and neutralized (20). [“H]Inositol phosphates were 
quantitated by liquid scintillation spectrometry after anion exchange 
chromatography on Bio-Rad AGl-X8 (200-400 mesh) as described 
(13). PLC activity against exogenously provided PtdIns(4,5)P, was 
determined as described (12). 
Protein Assay-Protein was determined by the method of Bradford 
(21) using bovine serum albumin as standard. Particulate material 
was warmed in 0.1 M NaOH and neutralized before assay. 
RESULTS 
Reconstitution of Purified Turkey Erythrocyte PLC with 
pH]Inositol-labeled Turkey Erythrocyte Ghosts-Ghosts pre- 
pared from turkey erythrocytes labeled to high specific radio- 
activity with [3H]inositol (average specific radioactivity of 
PtdIns(4,5)P, = 0.5 Ci/mmol) were used as acceptor mem- 
branes for the reconstitution of turkey erythrocyte PLC pu- 
rified as described in the accompanying manuscript (12). PLC 
activity was typically determined in incubations containing 
10 pg of ghost protein. This amount of protein is 10 to 20 
times less than that used in our previous studies of the 
receptor and G-protein-regulated PLC of turkey erythrocyte 
ghosts (13, 14, 22,23). In contrast to these reports, under the 
conditions used for the experiment presented in Table I, there 
was little measurable stimulation of PLC activity by 10 PM 
GTPrS alone, and 10 pM GTPrS in combination with a 
maximally effective concentration of the P2Y-purinergic recep- 
tor agonist ADPpS elicited a comparatively modest activation 
of PLC. In the experiment illustrated in Table I, addition of 
10 ng of purified turkey erythrocyte PLC to the ghosts had 
no effect on the formation of inositol phosphates determined 
under basal conditions or in the presence of ADP/3S alone. 
We have occasionally noted small increases in basal PLC 
activity upon reconstitution of the purified PLC (see Fig. 8). 
However, in the presence of the purified 150-kDa turkey 
erythrocyte PLC, inositol phosphate formation in response to 
TABLE I 
Reconstitution of purified turkey erythrocyte PLC with PHjinositol- 
labeled turkey erythrocyte ghosts 
[3H]Inositol-labeled turkey erythrocyte ghosts were prepared as 
described under “Experimental Procedures.” The ghosts (10 Fg of 
protein/assay in a final volume of 200 ~1) were incubated at 30 “C for 
5 min under basal conditions or in the presence of 10 pM ADPpS or 
10 pM GTPrS either singly or in combination as indicated in the 
table. In some cases, purified turkey erythrocyte PLC or purified PLC 
that had been inactivated by boiling for 5 min (10 rig/assay) was 
added to the ghosts immediately before dilution into the final assay. 
The incubations were terminated, and [3H]inositol phosphate for- 
mation was quantitated as described. The data presented are means 
+ S.E. of triplicate determinations from which a zero time value of 
2139 + 78 dpm has been subtracted. A similar phenomenon has been 
observed in many other experiments. 
[3H]Inositol phosphates formed 




Basal 65 f 24 117 f 35 39 + 25 
10 PM GTPrS 178 f 11 1,767 + 100 170 + 25 
10 PM ADPpS 23 + 2 23 + 1 33 + 8 
10 /.IM GTPrS 1,094 + 92 14,220 + 373 1,740 f 201 
+ 10 FM ADPpS 
0 25 50 75 100 
J 
Protein content of acceptor ghosts (ug/assay) 
FIG. 1. Dependence of PLC reconstitution on acceptor mem- 
brane concentration. [3H]Inositol-labeled turkey erythrocyte 
ghosts were prepared, and their protein content was determined. The 
amount of ghost protein in a 200~~1 final assay volume was varied 
from 1 to 100 pg. [3H]Inositol phosphate release from the ghosts was 
determined under basal conditions (U) or during stimulation 
with 10 PM ADP@S and 10 pM GTP-yS (O---O, A-A). In some 
cases (A-A), purified turkey erythrocyte PLC (10 rig/assay) was 
added to the ghosts. The data presented are means of triplicate 
determinations expressed as a percentage of the total amount of [“HI 
inositol-labeled lipid originally present in each incubation. A zero 
time value which ranged from 0.05 to 0.2% of the total [3H]Inositol- 
labeled lipid present in each incubation has been subtracted from the 
data shown. 
GTPyS was markedly enhanced and was dramatically ampli- 
fied in the combined presence of ADPfiS and GTPyS. Purified 
turkey erythrocyte PLC that had been inactivated by boiling 
prior to reconstitution had no effect on either GTPyS or 
GTPyS- plus ADPPS-promoted inositol phospholipid hydrol- 
ysis when combined with the ghosts. 
Dependence of PLC Reconstitution on Acceptor Membrane 
Protein Concentration-The dependence on acceptor mem- 
brane concentration for restoration of PZY-purinergic receptor 
agonist- and guanine nucleotide-stimulated inositol lipid hy- 
drolysis elicited by reconstitution of the purified PLC was 
investigated (Fig. 1). Inositol phosphate formation was deter- 
mined under basal and ADPPS- plus GTPyS-stimulated con- 
ditions after reconstitution of 10 ng of purified PLC with 1 to 
100 fig of [3H]inositol-labeled turkey erythrocyte ghost pro- 
tein. The magnitude of agonist and guanine nucleotide-stim- 
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ulated release of [3H]inositol phosphates from the ghosts 
expressed as a percentage of total [3H]inositol-labeled lipids 
decreased with increasing dilution of the ghost membranes. 
Agonist and guanine nucleotide-stimulated PLC activity was 
reduced markedly with less than 10 pg of protein in the assays 
and was maximal with 100 pg of ghost protein. Reconstitution 
of 10 ng of purified PLC resulted in a substantial increase in 
agonist and guanine nucleotide-stimulated inositol lipid hy- 
drolysis under conditions where no activation of endogenous 
PLC was observed (l-10 pg of membrane protein) and re- 
sulted in augmentation of the [3H]inositol phosphate forma- 
tion observed with amounts of acceptor protein in the range 
of 20-50 pg. Activity of the reconstituted PLC was only 
expressed in the presence of ADP/3S and GTPrS. That is, 
basal activity was identical in both the presence and absence 
of the purified PLC (Fig. 1). 
Dependence of Receptor-stimulated Inositol Phosphate Ac- 
cumulation on the Amount of Reconstituted PLC-The con- 
centration dependence of the effect of purified PLC on agonist 
and guanine nucleotide-stimulated inositol lipid hydrolysis 
was investigated by the reconstitution of increasing amounts 
of enzyme (0.01-200 ng) with 10 pg of [3H]inositol-labeled 
turkey erythrocyte ghosts. GTP was used instead of GTPyS 
in these experiments since, in the presence of this nucleotide, 
receptor activation of PLC occurs more rapidly than with 
GTP-& yet the steady state rate of PLC activity attained is 
lower with GTP than that attained with GTPrS (13). This 
strategy was used to minimize substrate limitation of PLC 
activity. ADP/3S in the presence of GTP produced a negligible 
accumulation of inositol phosphates in the absence of added 
enzyme (Fig. 2). An increase in ADPPS- plus GTP-stimulated 
inositol lipid hydrolysis was apparent with reconstitution of 
as little as 1 ng of the purified PLC. Agonist and guanine 
nucleotide-stimulated inositol phosphate formation increased 
with increasing amounts of the purified PLC. This effect was 
half-maximal with 5 ng of the purified PLC and maximal with 
100-200 ng. In the absence of agonist plus GTP, the purified 
PLC did not significantly increase inositol phosphate forma- 
tion at any of the concentrations tested (data not shown). 
Effect of Purified PLC on the Concentration Dependence for 
ng PLC added 
FIG. 2. Dependence of receptor-stimulated inositol phos- 
phate accumulation on the amount of reconstituted PLC. In- 
creasing amounts of purified turkey erythrocyte PLC were combined 
with [3H]inositol-laheled turkey erythrocyte ghosts (10 fig/assay), 
and [3H]inositol phosphate formation was determined in response to 
10 GM ADPPS and 1 mM GTP. The data presented are means of 
triplicate determinations. Basal inositol phosphate formation was 
unaltered by addition of the purified PLC (2734 + 234 dpm). The 
agonist-stimulated PLC activity expressed by the ghosts in the ab- 
sence of the purified PLC (6736 + 39 dpm) has been subtracted from 
the data shown. This experiment has been repeated twice with similar 
results. 
Activators of G-protein-regulated PLC-Concentration-effect 
curves for the activation of PLC in turkey erythrocyte ghosts 
were determined for ADPpS in the presence of 1 mM GTP 
(Fig. 3), for GTPyS (Fig. 4), and for NaF (assayed in the 
presence of 25 pM AlC& (data not shown). An amount of 
acceptor protein was chosen that gave a measurable endoge- 
nous PLC activity (20 Kg, see Fig. l), and this was compared 
with the activity expressed in the presence of the purified 
PLC (50 rig/assay). The magnitude of inositol phospholipid 
hydrolysis was increased in the presence of the purified PLC 
(Figs. 3 and 4), but the Koa values for each of the activators 
was the same irrespective of whether they were determined 
in the presence or the absence of the purified PLC. 
Kinetics of Activation of the Reconstituted Purified PLC- 
Boyer et al. (13) demonstrated that PZY-purinergic receptor 
agonists increased the rate of activation of PLC by GTPyS 
in a concentration-dependent and saturable manner. Experi- 
0 
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FIG. 3. Concentration dependence of ADPSS for stimulation 
of reconstituted PLC versus endogenous PLC activity. The 
concentration effect relationship with which ADPpS stimulated ino- 
sitol lipid hydrolysis in the presence of 1 mM GTP was determined 
using [3H]inositol-labeled turkey erythrocyte ghosts (20 pg/assay) in 
the absence (W) or presence (W) of reconstituted PLC (50 
ng). The data presented are means of triplicate determinations. 
Inositol phosphate accumulation stimulated by GTP alone has been 
subtracted from the data shown. 
9 Log [GTPyS] 
FIG. 4. Concentration dependence of GTPrS for stimulation 
of reconstituted PLC versus endogenous PLC activity. The 
concentration dependence for GTPrS stimulation of inositol lipid 
hydrolysis was investigated in turkey erythrocyte ghosts (20 gg) in 
the absence (o---O) or in the presence (W) of reconstituted 
PLC (50 rig/assay). The data are means of triplicate determinations. 
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ments were performed to compare the kinetics of activation 
of the endogenous PLC activity of turkey erythrocyte ghosts 
with that of the purified PLC when reconstituted with these 
ghosts. [3H]Inositol-labeled turkey erythrocyte ghosts (20 Fg 
of protein per assay) were incubated with and without 100 PM 
ADPpS and 10 PM GTPyS in the presence and absence of 
the purified PLC (50 rig/assay). The time course of activation 
of PLC was determined. The rate of activation of PLC was 
the same in each case. Only the maximal rate attained was 
increased in the presence of the purified PLC (Fig. 5 and 
inset). A series of similar experiments demonstrated that the 
first order rate constant (&,J for the activation of PLC was 
independent of the amount of PLC added to the ghosts (I& 
= 0.85 + 0.08 min-‘, mean f S.E. of five triplicate determi- 
nations using increasing amounts of the purified PLC in the 
range of 5-100 ng). GDP&S blocks guanine nucleotide-de- 
pendent activation of PLC in turkey erythrocyte ghosts (13). 
Although we did not attempt a precise quantitative analysis 
of this phenomenon, we also found that the rate of inactiva- 
tion of PLC observed on addition of competing concentrations 
of GDP&S following preactivation with agonist plus GTP or 
GTPyS was similar for endogenous PLC and the purified 
150-kDa PLC reconstituted into acceptor membranes. That 
is, return of PLC to basal levels of activity was rapid with 
agonist plus GTP, but much slower following preactivation 
with agonist plus GTPyS (not shown). 
Co-purification of the Receptor and G-protein-regulated PLC 
with PLC Activity against Exogenowly Provided Substrates- 
We used the reconstitution assay described above to follow 
PLC activity during purification from turkey erythrocyte 
cytosol(l2). Although PLC activity against exogenously pro- 
vided substrates was readily detectable in both unfractionated 
turkey erythrocyte cytosol and in the resuspended fraction 
obtained following precipitation with 226 g/liter (NH&SO+ 
we could not demonstrate a restoration of receptor and G- 
protein-regulated PLC activity when this material or fractions 
containing PLC activity following chromatography on Q- 
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FIG. 5. Kinetics of activation of the reconstituted PLC. This 
experiment was performed as described (13). [3H]Inositol-labeled 
turkey erythrocyte ghosts (20 pg/assay) were incubated in a contin- 
uously stirring vessel. Where appropriate, purified turkey erythrocyte 
PLC (50 rig/assay) was reconstituted (A) with the ghosts prior to the 
addition of drugs. Inositol phosphate formation was determined fol- 
lowing the addition of either assay buffer (0) or assay buffer that 
contained 100 pM ADPpS and 10 pM GTPyS (0, A). The data 
presented are single determinations and are representative of results 
from four experiments. The inset shows a semilogarithmic plot of 
PLC activity at time t (V,) expressed as a fraction of the maximal 
activity (V,,,..) attained against time (t). Note that in this experiment, 
in the absence of hormonal activators, PLC activity was unaltered by 
addition of the purified PLC to the ghosts, and only basal activity 
determined in the absence of the PLC is shown for clarity (0). 
tol-labeled turkey erythrocyte ghosts. By comparison with 
reconstitution experiments using the purified PLC, the large 
dilution and high salt content of the PLC preparation at these 
early steps makes it impossible to introduce sufficient enzyme 
into the reconstitution assay to produce a readily detectable 
receptor-stimulated accumulation of inositol phosphates. By 
the third and subsequent chromatographic steps (heparin- 
Sepharose, Sephacryl S-300, and Mono Q), reconstitution of 
agonist-stimulated inositol phosphate accumulation could be 
detected. Receptor-regulated PLC activity and PLC activity 
directed against exogenously provided substrates were coin- 
cident during elution in each of these column steps (not shown 
for the heparin-Sepharose and Sephacryl S-300 steps). The 
chromatographic behavior of receptor-stimulated PLC activ- 
ity and PLC activity detected using exogenously provided 
substrate are illustrated in Fig. 6 for the final purification 
step of anion exchange chromatography on Mono Q. 
Ca” Dependence of Reconstituted PLC Activity-In the 
absence of hormonal activators, PLC activity of turkey eryth- 
rocyte ghosts is markedly insensitive to activation by Ca”+ in 
the range lo-* to 10e3 M, and GTPyS-activated PLC in this 
membrane preparation is potentiated by Ca2+ in the range 
0.02-l fiM, although the Ca*+ dependence of P,y-purinergic 
receptor-promoted activation of PLC has not been investi- 
gated (22). Fig. 7 illustrates the dependence of polyphosphoi- 
nositide hydrolysis on Ca” determined under basal conditions 
or during activation with 10 gM GTPrS alone or in combi- 
nation with 10 pM ADPpS using 40 pg of turkey erythrocyte 
ghosts per assay (left panel) or the same amount of ghosts 
reconstituted with approximately 50 ng of purified PLC (right 
panel). In the native ghosts, basal PLC activity was unaltered 
by increasing the calcium concentration from 20 nM to 1 mM, 
although in the presence of the purified PLC a small Ca’+- 
dependent increase in basal PLC activity was observed (see 
above). In both cases, GTPyS and GTP$S- plus ADPPS- 
stimulated polyphosphoinositide hydrolysis was markedly de- 
pendent on Ca’+, with Ca2+ having both stimulatory and 
f6- 
, 
FIG. 6. Co-purification of receptor and G-protein-regulated 
PLC with PLC activity against exogenously provided sub- 
strates. PLC was purified from turkey erythrocyte cytosol as de- 
scribed previously (12). The pooled fractions containing PLC activity 
obtained after the second step of gel filtration chromatography on 
Sephacryl S-300 were applied to a Pharmacia Mono Q HR lO/lO 
anion exchange fast protein liquid chromatography column, and the 
column eluted with a gradient of NaCl as described (12). Fractions 
(0.3 ml) of the eluant were collected and assayed for PLC activity 
using exogenously provided PtdIns(4,5)P2 as described. The fractions 
also were assayed for their capacity to reconstitute P,v-purinergic 
receptor-stimulated PLC activity when combined with [“Hlinositol- 
labeled turkey erythrocyte ghosts using 2 ~1 of each fraction per assay 
combined with approximately 20 rg of ghost protein and conditions 
which were otherwise identical with those previously described (Table 
I). The values presented for the exogenous substrate assay are means 
of duplicate determinations while the reconstitution assays were 
performed in triplicate. Endogenous agonist plus guanine nucleotide- 
stimulated PLC activity of the acceptor ghosts has been subtracted 
from the data shown. 
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FIG. I. Ca2+ dependence of endogenous versus reconstituted 
PLC activity. Inositol linid hvdrolvsis was determined under basal 
conditions (u) or In the presence of 10 pM GTPrS alone 
(A-A) or in combination with 10 pM ADP/3S (W). The 
concentration of Ca2+ in the incubations was varied using Ca2+ EGTA 
buffers as described in the text. The left panel shows PLC activity 
determined using 40 pg of ghost protein, while the right panel shows 
PLC activity determined using the same amount of protein reconsti- 
tuted with 50 ng of purified PLC. 
inhibitory effects on enzyme activity. The concentration de- 
pendence for the stimulatory effect of Ca2+ was similar for 
both activating conditions, with half-maximal activation oc- 
curring at around 50 nM Ca2+ and maximal activity attained 
between 0.5 and 2.0 PM. Higher concentrations exerted an 
inhibitory effect on PLC activity. This inhibitory effect was 
half-maximal with approximately 100 @M Ca*’ and again, 
both GTP-yS and GTP$S- plus ADPPS-stimulated activity 
showed a similar Ca*+ concentration dependence. These re- 
sults indicate that the Ca2+ dependence of the endogenous 
PLC activity of turkey erythrocyte ghosts and of the purified 
PLC reconstituted with turkey erythrocyte ghosts are very 
similar. In the turkey erythrocyte system, hormonal activation 
of PLC seems to occur without a change in the Ca*+ depend- 
ence of the enzyme which is in contrast to the reported effects 
of agonists and guanine nucleotides on PLC activity observed 
in other cell types (1,ll). In addition, we note that dependence 
of the purified PLC on Ca2+ for activity when assayed with 
exogenously provided polyphosphoinositide substrates (12) 
parallels the stimulatory requirement for Ca*+ shown by the 
reconstituted PLC acting on membrane phospholipid sub- 
strates. 
Substrate Selectivity of the Reconstituted PLC-The selec- 
tivity of the reconstituted PLC for the three inositol lipids 
was assessed by anion exchange high performance liquid 
chromatography analysis of the water-soluble inositol phos- 
phates formed in response to maximally effective concentra- 
tions of ADPpS and GTP-S. Use of an amount of acceptor 
ghosts which themselves expressed PLC activity (20 Fg, see 
Fig. 2) permitted a direct comparison of the reconstituted 
PLC with its endogenous counterpart. Consistent with our 
previous observations of the substrate selectivity of the en- 
dogenous PLC activity of turkey erythrocyte ghosts (22) and 
with the high specificity of the purified turkey erythrocyte 
PLC for the polyphosphoinositides when assayed with exog- 
enously provided substrates (12), the only inositol phosphates 
formed were Ins(l,4)P, and Ins(1,4,5)P3 (data not shown). 
The Ins(l,4)P2 may be derived by either direct PLC-catalyzed 
hydrolysis of PtdIns4P or by the subsequent dephosphoryla- 
tion of PLC-generated Ins(1,4,5)P3 catalyzed by Ins(1,4,5)P3- 
5-phosphatase also present in the ghosts (24). 
DISCUSSION 
PLC-catalyzed inositol lipid hydrolysis is an important 
mechanism of signal transduction employed by many cell 
surface receptors. A number of isoenzymes of PLC have been 
identified and purified from several different sources, yet their 
roles in the intact cell remain undefined. A conundrum which 
has contributed to this confusion concerns the subcellular 
distribution of PLC. When assayed with exogenously provided 
substrates, PLC activity has been found to be predominantly 
cytosolic in many different tissues (see Ref. 2 for review). The 
identified isoenzymes of PLC, including the turkey erythro- 
cyte-derived enzyme, are stable soluble proteins that can be 
extracted from tissues and purified without exposure to de- 
tergents. Although membrane-associated PLC activity has 
been observed in many tissue preparations, some degree of 
extraction often could be effected by washing the membranes 
with salt (for example, Ref. 25). The most extensive study of 
this type (26) demonstrated by structural and immunological 
criteria that a PLC isoenzyme associated with bovine brain 
membranes (PLC-/3 and a truncated form of this protein) was 
identical with a previously purified soluble protein (see also 
Refs. 27 and 28). Consistent with these observations, the 
known primary sequences of three PLC isoenzymes do not 
reveal any regions of sufficient hydropathicity to suggest that 
they may function in membrane insertion or anchoring of the 
proteins (28-31). 
These observations are surprising because the phospholipid 
substrates of PLC and the cell surface receptors that control 
PLC activity are clearly integral components of the plasma 
membrane. The observation of guanine nucleotide-dependent 
decreases in agonist affinity of PLC-coupled receptors in 
washed membrane preparations (1, 3, 4) and the reported 
effects of G-protein P-y subunits on receptor regulation of 
PLC (23, 32) support a role for a heterotrimeric, plasma 
membrane-localized G-protein in the activation of PLC. 
Thus, either receptor-regulated PLC is stably associated with 
the plasma membrane yet has evaded purification, or a soluble 
form of PLC interacts with the plasma membrane and is 
indeed regulated by G-protein-linked cell surface receptors. 
The results presented in this manuscript provide evidence 
in support of the latter proposal. That is, an isoenzyme of 
PLC has been purified from the cytosolic fraction of turkey 
erythrocytes and, when reconstituted with turkey erythrocyte 
ghosts, its catalytic activity against endogenously labeled 
polyphosphoinositides is regulated by G-protein-linked P2y- 
purinergic receptors. The idea that a cytosolic PLC might be 
regulated by receptors is not a new one. Irvine et al. (33, 34) 
originally suggested that a stimulus-provoked association of 
a soluble PLC with the plasma membrane was a possible 
means by which cell surface receptors controlled inositol lipid 
hydrolysis. More recently, several groups have reported that 
guanine nucleotides activate crude preparations of soluble 
PLC from platelets, bovine brain, and calf thymocytes (35- 
37). In the studies using platelets and thymocytes, evidence 
has been presented for the physical association of soluble 
PLC with low molecular weight GTP-binding proteins (37, 
38). The role of cell surface receptors in the regulation of 
these enzymes is not yet clear. Furthermore, studies using 
purified isoenzymes of PLC suggest that nucleotides may have 
direct effects on PLC activity expressed against exogenously 
provided substrates (39). Finally, one report suggests a role 
for soluble PLC in receptor-stimulated formation of inositol 
phosphates from plasma membrane-localized inositol lipids. 
Baldassare and Fisher (35) observed an amplified thrombin- 
stimulated guanine nucleotide-dependent inositol lipid hy- 
drolysis when platelet cytosol was combined with [3H]inositol- 
prelabeled platelet plasma membranes. Further work with 
more defined preparations of platelet PLC has not been 
reported. By contrast, we have been unable to demonstrate 
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guanine nucleotide regulation of PLC activity in turkey eryth- 
rocyte cytosol,’ and, as discussed above, our evidence suggests 
a plasma membrane localization of the Pzy-purinergic recep- 
tor-linked G-protein in this tissue (23, 40). 
Our findings raise several important questions about the 
factors that determine the subcellular distribution of PLC in 
turkey erythrocytes. The data obtained imply that the inter- 
action of PLC with the plasma membrane is a dynamic 
process. Central to our ability to reconstitute the purified 
turkey erythrocyte PLC with turkey erythrocyte ghosts is the 
observation that the endogenous PLC activity of the ghosts 
does not decrease proportionately when the ghosts are diluted 
into a fixed assay volume. These results imply that under the 
conditions used for preparation of the ghosts the putative 
components of the inositol lipid-dependent signalling system 
(that is, the PLC, its substrates and the receptor and associ- 
ated G-protein that regulate it) do not behave as physically 
associated entities. The restoration of agonist and guanine 
nucleotide-regulated inositol lipid hydrolysis by the addition 
of the purified turkey erythrocyte PLC suggests that the lesion 
responsible for the observed reduction in agonist-stimulated 
inositol lipid hydrolysis involves a loss of PLC from the ghost 
membranes. However, we do not have any unambiguous ex- 
perimental evidence to support this idea. Unfortunately at 
present we can only quantitate receptor-regulated PLC by 
measuring its catalytic activity expressed against endoge- 
nously labeled substrates, and this constraint makes it impos- 
sible to assess the partitioning of PLC between membranes 
and the soluble phase during receptor activation or during the 
preparation of acceptor ghosts for reconstitution experiments. 
The catalytic and regulatory properties of the purified PLC 
when reconstituted with turkey erythrocyte ghosts and acti- 
vated by the G-protein-linked P,v-purinergic receptor are 
identical with those of the endogenous PLC activity of turkey 
erythrocyte ghosts (13, 22). This raises the possibility that 
the ghost-associated PLC and the purified cytosolic PLC are 
the same protein. Pertinent to this question we note that [3H] 
inositol-labeled turkey erythrocyte plasma membranes pre- 
pared using the nitrogen cavitation method employed to gen- 
erate the cytosolic fraction from which the PLC was purified 
do not show hormonally regulated PLC activity’ and contain 
less than 1% of cellular PLC activity determined using exog- 
enously provided substrates (12). Reconstitution of the puri- 
fied 150-kDa turkey erythrocyte PLC with these membranes 
restores G-protein-regulatedpolyphosphoinositide hydrolysis, 
although the relative efficacies of G-protein activators are 
somewhat different from those observed with the ghost recon- 
stitution system.’ Finally, the precise nature of PLC mem- 
brane interaction remains obscure. In vitro experiments using 
phospholipid vesicles and purified PLC isoenzymes support a 
simple model in which PLC association with membranes is a 
substrate-directed process (41, 42). However, it is equally 
plausible that plasma membrane association of PLC is me- 
diated through an as yet undefined but specific interaction 
with a protein or non-substrate lipid constituent of the plasma 
membrane. The preparation of specific antisera against the 
turkey erythrocyte PLC should provide an activity-independ- 
ent means of detecting the enzyme and ultimately provide 
answers to some of the above questions. 
Many questions remain. Can other isoenzymes of PLC also 
be regulated by the P,y-purinergic receptor in the turkey 
erythrocyte reconstitution system? Will similar strategies 
prove suitable for examining receptor regulation of PLC in 
other cell types? Although supported by several lines of evi- 
‘A. J. Morris, G. L. Waldo, and T. K. Harden, unpublished 
observations. 
dence, our supposition that PZy-purinergic receptor regulation 
of PLC in turkey erythrocytes occurs by mechanisms analo- 
gous to other better understood G-protein-linked second mes- 
senger generating systems is still marred by our inability to 
identify the relevant G-protein. We hope that our identifica- 
tion of a G-protein-linked, receptor-regulated PLC will allow 
us to design a functional assay to facilitate the purification of 
the putative PZy-purinergic receptor-linked G-protein from 
turkey erythrocytes. Finally, the ability to simply achieve 
functional reconstitution of an effector protein with the reg- 
ulatory components of a G-protein-controlled system should 
eventually lead us to a better understanding of G-protein- 
effector coupling. 
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